(Q36891616)

16 August 2017

title

Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes (English)

1 reference

16 August 2017

Chung HS

1

1 reference

16 August 2017

Shin DH

2

1 reference

16 August 2017

Birt CM

3

1 reference

16 August 2017

Kim C

4

1 reference

16 August 2017

Lee D

5

1 reference

16 August 2017

Levin DS

6

1 reference

16 August 2017

Hakimzadeh R

7

1 reference

16 August 2017

Juzych MS

8

1 reference

16 August 2017

publication date

1 November 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

104

1 reference

16 August 2017

issue

11

1 reference

16 August 2017

page(s)

1921-1925

1 reference

Argon laser trabeculoplasty in the presurgical glaucoma patient.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Complications of laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

ALO 2145 reduces the intraocular pressure elevation after anterior segment laser surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Apraclonidine and argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Additive Effect of 1% Apraclonidine Hydrochloride to Nonselective β-Blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Pilocarpine and the increase in intraocular pressure after trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Apraclonidine and argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Nonsteroidal anti-inflammatory agents after argon laser trabeculoplasty. A trial with flurbiprofen and indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Effects of corticosteroid pretreatment on argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Prevention of the Rise in Intraocular Pressure Following Neodymium-YAG Posterior Capsulotomy Using Topical 1% Apraclonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Variation of techniques on the results of argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

Immediate intraocular pressure response to argon laser trabeculoplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930006-2

7 January 2021

10.1016/S0161-6420(97)30006-2

Identifiers

DOI

1 reference

16 August 2017

1 reference